
Along with Andrew J. Lipman, MD, participate in the management of a patient newly diagnosed with CTCL, including of the selection of proper staging techniques, the approach to patients with progressive disease, and the use of skin-directed or systemic treatments.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe proper staging techniques for patients newly diagnosed with CTCL
- Discuss the skin-directed and systemic therapies available for the treatment of patients with CTCL
- Review strategies for managing CTCL patients who progress or experienced therapy-related adverse events after treatment with skin-directed or systemic therapies